""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_component"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"additional_exposure_material"	"comparison"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"exposure_material_1"	"exposure_material_2"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	"vaccine"	"vaccine"	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	""	""	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"pathogen"	"background"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"vaccine"	"vaccine"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original)"	"response component (cell subset)"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"target pathogen"	"vaccine year"	"exposure material (name)"	"additional exposure material"	"comparison"	"cohort"	"publication reference (PMID)"	"publication year"	"figure or table or text section containing signature"	"comments and additional details"	"Grode et al. (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835' target='_blank'>23290835</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"exposure material 1 (VO)"	"exposure material 2 (VO)"	"signature response component file"
""	"hipc_ctf_23290835_2"	"2013.02"	"hipc_ctf_23290835_2"	"peripheral blood mononuclear cell"	"IFN-y+ CD4 T cells"	"CD4-positive, alpha-beta T cell"	"CL_0000624"	"& IFNG+"	"PR:000000017"	"CD4-positive, alpha-beta T cell & IFNG+"	"cell type frequency"	"up"	"none"	"57"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"BCG vaccine; VPM1002"	""	"57d-0d"	"adults (18-55)"	"23290835"	"2013"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"adults"	"18"	"55"	"years"	"2"	"58"	"VO_0000771"	"VO_0003131"	"hipc_ctf_sig_23290835_2.txt"
